A 2010 review summarizing key epidemiologic, pathophysiologic, and clinical trial developments in heart failure management.
Answers are grounded in this paper and cite their sources.
Provides historical HF context through 2010; leaves open relevance to post-2010 therapies and guidelines.
In spite of substantial improvement in outcomes in the past 2 decades, we continue to face significant challenges in treating patients with HF. There have been several epidemiologic, pathophysiologic, and randomized controlled trials evaluating different treatment modalities published in the past year. In this review, we summarize the most relevant studies that we believe could significantly impact the understanding and management of HF.
No takes yet. Share an insight, caveat, or question.
Gaddam et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: